Background: To eliminate hepatitis C (HCV) infection as a public health concern by 2030. there is a need to develop comprehensive programs among key populations such as people who use drugs (PWUD). Two highly effective regimens are available for initial therapy: glecaprevir/pibrentasvir (G/P) given as 3 tablets/day for 8 weeks and sofosbuvir/velpatasvir (S/V) given as 1 tablet/day for... https://www.sahmbuffy.com/product-category/ignitor/